Pacific Diabetes Technologies Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.92M
- Investors
-
6
Pacific Diabetes Technologies General Information
Description
Developer of hollow glucose sensor devices designed for continuous glucose monitoring and insulin delivery. The company's device aims to reduce the pain and daily disruption of managing insulin-treated diabetes and automated insulin delivery systems, enabling healthcare professionals to reduce needle trauma, and adhesive irritation, and improve adherence among pediatric and reluctant adult patient
Contact Information
Website
www.pacificdt.comCorporate Office
- 12172 SouthWest Garden Place
- Portland, OR 97223
- United States
Corporate Office
- 12172 SouthWest Garden Place
- Portland, OR 97223
- United States
Pacific Diabetes Technologies Timeline
Pacific Diabetes Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Later Stage VC | 20-Oct-2025 | $2.92M | Completed | Pre-Clinical Trials | ||
| 13. Later Stage VC (Series A1) | 13-Mar-2025 | Completed | Pre-Clinical Trials | |||
| 12. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 11. Later Stage VC (Series A) | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 10. Grant | 30-Jun-2022 | Completed | Pre-Clinical Trials | |||
| 9. Grant | 16-Jul-2021 | Completed | Pre-Clinical Trials | |||
| 8. Seed Round | 28-May-2021 | Completed | Pre-Clinical Trials | |||
| 7. Grant | 01-Jan-2019 | Completed | Pre-Clinical Trials | |||
| 6. Grant | 31-Mar-2017 | $1.15M | Completed | Pre-Clinical Trials | ||
| 5. Grant | 01-Jan-2017 | $225K | Completed | Startup |
Pacific Diabetes Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-5 | ||||||||
| Series A-4 | ||||||||
| Series A-3 | 144,216 | $0.000010 | 8% | $0.69 | $0.69 | 1x | $0.69 | 0.46% |
| Series A-2 | 582,240 | $0.000010 | 8% | $0.82 | $0.82 | 1x | $0.82 | 1.86% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Pacific Diabetes Technologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Pacific Diabetes Technologies Patents
Pacific Diabetes Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024209583-A1 | Self-inserting trocarless analyte-sensing cannula | Pending | 17-Jan-2023 | ||
| EP-4651798-A1 | Self-inserting trocarless analyte-sensing cannula | Pending | 17-Jan-2023 | ||
| US-20260000831-A1 | Self-inserting trocarless analyte-sensing cannula | Pending | 17-Jan-2023 | ||
| WO-2024155579-A1 | Self-inserting trocarless analyte-sensing cannula | Inactive | 17-Jan-2023 | ||
| US-12216074-B2 | Biosensors and methods for determining analyte concentration in the kinetic potential region of redox mediators | Active | 01-Oct-2021 | G01N27/26 |
Pacific Diabetes Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pacific Diabetes Technologies Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| TMD Ventures | Venture Capital | Minority | ||
| Breakthrough T1D | Not-For-Profit Venture Capital | |||
| National Institutes of Health | Government | |||
| The Leona M. and Harry B. Helmsley Charitable Trust | Limited Partner | |||
| National Institute of Diabetes and Digestive and Kidney Diseases | Government |
Pacific Diabetes Technologies FAQs
-
When was Pacific Diabetes Technologies founded?
Pacific Diabetes Technologies was founded in 2013.
-
Where is Pacific Diabetes Technologies headquartered?
Pacific Diabetes Technologies is headquartered in Portland, OR.
-
What is the size of Pacific Diabetes Technologies?
Pacific Diabetes Technologies has 15 total employees.
-
What industry is Pacific Diabetes Technologies in?
Pacific Diabetes Technologies’s primary industry is Monitoring Equipment.
-
Is Pacific Diabetes Technologies a private or public company?
Pacific Diabetes Technologies is a Private company.
-
What is Pacific Diabetes Technologies’s current revenue?
The current revenue for Pacific Diabetes Technologies is .
-
How much funding has Pacific Diabetes Technologies raised over time?
Pacific Diabetes Technologies has raised $17.6M.
-
Who are Pacific Diabetes Technologies’s investors?
TMD Ventures, Breakthrough T1D, National Institutes of Health, The Leona M. and Harry B. Helmsley Charitable Trust, and National Institute of Diabetes and Digestive and Kidney Diseases are 5 of 6 investors who have invested in Pacific Diabetes Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
